Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.096 NZD 10.34%
Market Cap: 77.9m NZD

P/OCF
Price to OCF

-3.4
Current
-4.7
Median
19.3
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-3.4
=
Market Cap
77.9m NZD
/
Operating Cash Flow
-23.2m NZD
Market Cap P/OCF
NZ
Pacific Edge Ltd
NZX:PEB
77.9m NZD -3.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -218 422
US
Abbvie Inc
NYSE:ABBV
341.6B USD 18.3
US
Amgen Inc
NASDAQ:AMGN
154.9B USD 13.5
US
Gilead Sciences Inc
NASDAQ:GILD
129.8B USD 12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.4B USD -263.3
US
Epizyme Inc
F:EPE
94.1B EUR -515
AU
CSL Ltd
ASX:CSL
118.8B AUD 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
62.4B USD 14
US
Seagen Inc
F:SGT
39.3B EUR -83.1
NL
argenx SE
XBRU:ARGX
33B EUR -453.7
 
NZ
Pacific Edge Ltd
NZX:PEB
Average P/OCF: 16.8
Negative Multiple: -3.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 422
US
Abbvie Inc
NYSE:ABBV
18.3
US
Amgen Inc
NASDAQ:AMGN
13.5
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -515
AU
CSL Ltd
ASX:CSL
25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -453.7

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A